article thumbnail

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

In 1999, Jesse Gelsinger, age 18, died four days after doctors at the University of Pennsylvania administered a corrective gene encased in a deactivated adenovirus. The treatment consists of inserting healthy genes into an affected individual’s affected cells and tissues to try and stop or treat the disease.

article thumbnail

Why Do Black Patients Fare Worse With Blood Cancer Than Whites?

The Pharma Data

The researchers said genetic analysis revealed differences within the cancer cells of Black and white patients with AML. Doctors now know that if a patient’s leukemia cells have certain genetic mutations, their chance of survival is typically better.